| Revenue growth | Value |
|---|---|
| 3Y CAGR | +12% |
| Profit growth | Value |
|---|---|
| 3Y CAGR | +14% |
| Stock | Mkt price (1D) | 52 week performance | Market cap | P/E ratio | P/B ratio | |
|---|---|---|---|---|---|---|
PfizerPFIZER | ₹4,881.50 -96.70 (1.94%) | 22,313.00 | 30.35 | 5.31 | ||
Caplin Point LaboratoriesCAPLIPOINT | ₹2,496.10 -64.70 (2.53%) | 18,975.94 | 27.99 | 5.29 | ||
Astrazeneca Pharma IndiaASTRAZEN | ₹7,232.00 -183.50 (2.47%) | 18,050.13 | 106.41 | 20.68 | ||
Natco PharmaNATCOPHARM | ₹884.05 +1.65 (0.19%) | 15,823.46 | 13.82 | 1.72 |